[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Kunc et al., 2019 - Google Patents

Polycarboxylated Dextran as a Multivalent Linker: Synthesis and Target Recognition of the Antibody–Nanoparticle Bioconjugates in PBS and Serum

Kunc et al., 2019

Document ID
6583366369737084314
Author
Kunc F
Moore C
Sully R
Hall A
Gubala V
Publication year
Publication venue
Langmuir

External Links

Snippet

Nanoparticles (NPs) functionalized with antibodies on their surface are used in a wide range of research applications. However, the bioconjugation chemistry between the antibodies and the surface of nanoparticles can be very challenging, often accompanied by several …
Continue reading at pubs.acs.org (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/587—Nanoparticles

Similar Documents

Publication Publication Date Title
Thielbeer et al. Zeta potential mediated reaction monitoring on nano and microparticles
Xi et al. Selection of HBsAg-specific DNA aptamers based on carboxylated magnetic nanoparticles and their application in the rapid and simple detection of hepatitis B virus infection
Puertas et al. Taking advantage of unspecific interactions to produce highly active magnetic nanoparticle− antibody conjugates
Xu et al. Core–shell molecularly imprinted polymer nanoparticles as synthetic antibodies in a sandwich fluoroimmunoassay for trypsin determination in human serum
Shipunova et al. Versatile platform for nanoparticle surface bioengineering based on SiO2-binding peptide and proteinaceous barnase* barstar interface
Liang et al. Iron oxide/gold core/shell nanoparticles for ultrasensitive detection of carbohydrate− protein interactions
Poselt et al. Tailor-made quantum dot and iron oxide based contrast agents for in vitro and in vivo tumor imaging
Xiong et al. Uniform fluorescent nanobioprobes for pathogen detection
Avvakumova et al. Biotechnological approaches toward nanoparticle biofunctionalization
Awotunde et al. Role of free thiol on protein adsorption to gold nanoparticles
Hwang et al. Think modular: a simple apoferritin-based platform for the multifaceted detection of pancreatic cancer
Yang et al. Polyelectrolyte-coated gold magnetic nanoparticles for immunoassay development: toward point of care diagnostics for syphilis screening
Koshkina et al. Temperature-triggered protein adsorption on polymer-coated nanoparticles in serum
Tang et al. Bifunctional Janus microparticles with spatially segregated proteins
Ruiz et al. Antibodies irreversibly adsorb to gold nanoparticles and resist displacement by common blood proteins
US10942178B2 (en) Long rigid spacers to enhance binding kinetics in immunoassays
GB2474456A (en) Dendrimer functionalised nanoparticle label
Okyem et al. Probing the mechanism of antibody-triggered aggregation of gold nanoparticles
Duan et al. Chitosan-stabilized self-assembled fluorescent gold nanoclusters for cell imaging and biodistribution in vivo
Wang et al. M13 phage: a versatile building block for a highly specific analysis platform
Pollok et al. Orientation-controlled bioconjugation of antibodies to silver nanoparticles
Kunc et al. Polycarboxylated Dextran as a Multivalent Linker: Synthesis and Target Recognition of the Antibody–Nanoparticle Bioconjugates in PBS and Serum
Leitner et al. Single-molecule AFM characterization of individual chemically tagged DNA tetrahedra
Maley et al. Measuring protein binding to individual hydrogel nanoparticles with single-nanoparticle surface plasmon resonance imaging microscopy
Hinman et al. DNA linkers and diluents for ultrastable gold nanoparticle bioconjugates in multiplexed assay development